LDS/Medical Tests/5-hydroxytryptamine receptor 1A (HTR1A)

5-hydroxytryptamine receptor 1A (HTR1A)

Depression and anxiety are two of the most common mental health problems in the US. Serotonin (5-hydroxytryptamine, HTR) is a neurotransmitter that is known to have effects on mood, depression and anxiety. The actions of serotonin are regulated by 14 types of receptors in neurons of the central and peripheral nervous system. HTR agonists and serotonin reuptake inhibitors (SSRIs) have been shown to be useful in treating both anxiety and depression. However, genetic polymorphisms in HTR receptors have been identified that may impact the efficacy of HTR agonist treatment and therefore studying HTR receptor polymorphisms may be important in therapy selection and efficacy.

Among one of the 14 receptors of serotonin is HTR1A, which is coded by the HTR1A gene located at 5q11.2-q13. HTR1A is a G-protein coupled receptor (GPCR) and is abundant in the presynaptic (auto-receptors; generally, inhibitory) and postsynaptic (heteroreceptors; typically reduce postsynaptic neural activity) endings of neurons in the central nervous system.

Currently, numerous single nucleotide polymorphisms on the HTR1A gene have been identified that may impact the serotonergic system and result in various psychiatric disorders. HTR1A agonist antidepressants such as Buspirone, Gepirone, and Pindolol might fail to treat cases where there are SNPs, affecting the HTR1A activity. Occasionally, few SNPs may result in the auto-activation of HTR1A and lower serotonin levels. Some of the SNPs identified are G-1019, G1018, Ile28Val, Arg219Leu, and Gly22Ser. Evaluation of HTR1A abnormalities includes a genetic examination of these SNPs or sequencing of the entire coding region.

  • As an aid in diagnosis and management of depression and anxiety
  • Aids in investigating unresponsive treatment to antidepressants
  • Helpful in diagnosing impaired serotonergic sleep and menstruation related disorders

A positive result indicates the presence of SNPs in the HTR1A gene and hence the individual is susceptible to depression and anxiety disorder.

A negative result indicates the absence of the targeted SNPs solely in the HTR1A gene. However, other unscreened SNPs may be the cause and it is advised to sequence the whole coding region instead. However, a negative test cannot rule out the individual’s susceptibility to depression since there are many other causes of depression/anxiety.

Negative for mutations analysis (no mutations or pathogenic variants detected)

Next-Generation Sequencing (NGS), Massively Parallel Sequencing (MPS), Sanger sequencing, Real-time Polymerase Chain Reaction (PCR).

Whole blood (preferred), Lavender-top (EDTA), buccal swab, saliva.

Stability Whole blood

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: 30 days
Plasma serotonin level, serum cortisol, dopamine, prolactin, total calcium, vitamin D, gene analysis for other serotonin receptors, positron emission tomography (PET).
3 to 5 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login